Quoin Pharmaceuticals Ltd...

AI Score

XX

Unlock

6.64
0.08 (1.22%)
At close: Apr 24, 2025, 3:58 PM

Quoin Pharmaceuticals Statistics

Share Statistics

Quoin Pharmaceuticals has 255.66K shares outstanding. The number of shares has increased by 135.73% in one year.

Shares Outstanding 255.66K
Shares Change (YoY) 135.73%
Shares Change (QoQ) 77.2%
Owned by Institutions (%) 0.03%
Shares Floating 8.31M
Failed to Deliver (FTD) Shares 76.41K
FTD / Avg. Volume 32.25%

Short Selling Information

The latest short interest is 174.01K, so 0.85% of the outstanding shares have been sold short.

Short Interest 174.01K
Short % of Shares Out 0.85%
Short % of Float 0.91%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -15. Quoin Pharmaceuticals's PEG ratio is 0.

PE Ratio 0
Forward PE -15
PS Ratio 0
Forward PS 0
PB Ratio 0
P/FCF Ratio 0
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Quoin Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.

Current Ratio 3.57
Quick Ratio 3.57
Debt / Equity 0
Debt / EBITDA -
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-2.99B
Employee Count 3
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 858.71% in the last 52 weeks. The beta is 1.61, so Quoin Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.61
52-Week Price Change 858.71%
50-Day Moving Average 5.49
200-Day Moving Average 1.82
Relative Strength Index (RSI) 49.82
Average Volume (20 Days) 236.92K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income 0
Net Income -8.96B
EBITDA 0
EBIT n/a
Earnings Per Share (EPS) -1911.5
Full Income Statement

Balance Sheet

The company has 3.62B in cash and 0 in debt, giving a net cash position of 3.62B.

Cash & Cash Equivalents 3.62B
Total Debt 0
Net Cash 3.62B
Retained Earnings -55.17B
Total Assets 15.71B
Working Capital 10.75B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.86B and capital expenditures 0, giving a free cash flow of -7.86B.

Operating Cash Flow -7.86B
Capital Expenditures 0
Free Cash Flow -7.86B
FCF Per Share -1675.79
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

QNRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for QNRX is $4, which is -34% lower than the current price. The consensus rating is "Buy".

Price Target $4
Price Target Difference -34%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Jul 18, 2023. It was a backward split with a ratio of 1:12.

Last Split Date Jul 18, 2023
Split Type backward
Split Ratio 1:12

Scores

Altman Z-Score -4.1
Piotroski F-Score 2